Literature DB >> 30060809

Ceramide Signaling and p53 Pathways.

Kristen A Jeffries1, Natalia I Krupenko2.   

Abstract

Ceramides, important players in signal transduction, interact with multiple cellular pathways, including p53 pathways. However, the relationship between ceramide and p53 is very complex, and mechanisms underlying their coregulation are diverse and not fully characterized. The role of p53, an important cellular regulator and a transcription factor, is linked to its tumor suppressor function. Ceramides are involved in the regulation of fundamental processes in cancer cells including cell death, proliferation, autophagy, and drug resistance. This regulation, however, can be pro-death or pro-survival depending on cancer type, the balance between ceramide species, the rate of their synthesis and utilization, and the availability of a specific array of downstream targets. This chapter highlights the central role of ceramide in sphingolipid metabolism, its role in cancer, specific effectors in ceramide pathways controlled by p53, and coregulation of ceramide and p53 signaling. We discuss the recent studies, which underscore the function of p53 in the regulation of ceramide pathways and the reciprocal regulation of p53 by ceramide. This complex relationship is based on several molecular mechanisms including the p53-dependent transcriptional regulation of enzymes in sphingolipid pathways, the activation of mutant p53 through ceramide-mediated alternative splicing, as well as modulation of the p53 function through direct and indirect effects on p53 coregulators and downstream targets. Further insight into the connections between ceramide and p53 will allow simultaneous targeting of the two pathways with a potential to yield more efficient anticancer therapeutics.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer therapeutics; Ceramide signaling; Metabolism; Transcriptional regulation; Tumor suppression; p53

Mesh:

Substances:

Year:  2018        PMID: 30060809      PMCID: PMC6361168          DOI: 10.1016/bs.acr.2018.04.011

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  114 in total

1.  Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.

Authors:  Yong-Yu Liu; Gauri A Patwardhan; Kaustubh Bhinge; Vineet Gupta; Xin Gu; S Michal Jazwinski
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

2.  Noncoding RNAs: the missing "linc" in p53-mediated repression.

Authors:  Anthony M Barsotti; Carol Prives
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

3.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

Review 4.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

5.  Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression.

Authors:  Shang-Jui Wang; Dawei Li; Yang Ou; Le Jiang; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell Rep       Date:  2016-10-04       Impact factor: 9.423

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Mitochondrially targeted ceramides preferentially promote autophagy, retard cell growth, and induce apoptosis.

Authors:  Qi Hou; Junfei Jin; Hui Zhou; Sergei A Novgorodov; Alicja Bielawska; Zdzislaw M Szulc; Yusuf A Hannun; Lina M Obeid; Yi-Te Hsu
Journal:  J Lipid Res       Date:  2010-11-16       Impact factor: 5.922

8.  Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells.

Authors:  Judith Mesicek; Hyunmi Lee; Taya Feldman; Xuejun Jiang; Anastasia Skobeleva; Evgeny V Berdyshev; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Cell Signal       Date:  2010-04-18       Impact factor: 4.315

9.  Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide.

Authors:  L R Ballou; C P Chao; M A Holness; S C Barker; R Raghow
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

10.  Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.

Authors:  Salman B Hosain; Sachin K Khiste; Mohammad B Uddin; Vindya Vorubindi; Catherine Ingram; Sifang Zhang; Ronald A Hill; Xin Gu; Yong-Yu Liu
Journal:  Oncotarget       Date:  2016-09-13
View more
  15 in total

1.  Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Authors:  Sachin K Khiste; Zhijun Liu; Kartik R Roy; Mohammad B Uddin; Salman B Hosain; Xin Gu; Sami Nazzal; Ronald A Hill; Yong-Yu Liu
Journal:  Mol Cancer Ther       Date:  2019-10-23       Impact factor: 6.261

Review 2.  Ceramide signaling in the gut.

Authors:  Ying Li; Rebekah J Nicholson; Scott A Summers
Journal:  Mol Cell Endocrinol       Date:  2022-01-05       Impact factor: 4.102

3.  Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.

Authors:  Kimberley Joanne Hatfield; Øystein Bruserud; Håkon Reikvam
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

4.  Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.

Authors:  Henryk Jęśko; Przemysław L Wencel; Sylwia Wójtowicz; Joanna Strosznajder; Walter J Lukiw; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2020-04-30       Impact factor: 5.590

Review 5.  Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System.

Authors:  Paweł Knapp; Karolina Chomicz; Magdalena Świderska; Adrian Chabowski; Robert Jach
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

6.  Alkaline Ceramidase Mediates the Oxidative Stress Response in Drosophila melanogaster Through Sphingosine.

Authors:  Chun-Hong Zhang; Min-Jing Zhang; Xiao-Xiao Shi; Cuigui Mao; Zeng-Rong Zhu
Journal:  J Insect Sci       Date:  2019-05-01       Impact factor: 1.857

Review 7.  Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.

Authors:  Matthieu Lacroix; Romain Riscal; Giuseppe Arena; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Metab       Date:  2019-10-18       Impact factor: 7.422

8.  C16-ceramide is a natural regulatory ligand of p53 in cellular stress response.

Authors:  Baharan Fekry; Kristen A Jeffries; Amin Esmaeilniakooshkghazi; Zdzislaw M Szulc; Kevin J Knagge; David R Kirchner; David A Horita; Sergey A Krupenko; Natalia I Krupenko
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

9.  Ceramide Synthase 6 Maximizes p53 Function to Prevent Progeny Formation from Polyploid Giant Cancer Cells.

Authors:  Ping Lu; Shai White-Gilbertson; Gyda Beeson; Craig Beeson; Besim Ogretmen; James Norris; Christina Voelkel-Johnson
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.575

10.  Anticancer Effects of New Ceramides Isolated from the Red Sea Red Algae Hypnea musciformis in a Model of Ehrlich Ascites Carcinoma: LC-HRMS Analysis Profile and Molecular Modeling.

Authors:  Sameh S Elhady; Eman S Habib; Reda F A Abdelhameed; Marwa S Goda; Reem M Hazem; Eman T Mehanna; Mohamed A Helal; Khaled M Hosny; Reem M Diri; Hashim A Hassanean; Amany K Ibrahim; Enas E Eltamany; Usama Ramadan Abdelmohsen; Safwat A Ahmed
Journal:  Mar Drugs       Date:  2022-01-10       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.